−14.0
Acrivon Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−30.1
FY23:
−42.6
FY24:
−65.7
FY25:
−63.7
Change from FY21 to FY25
millions USD
FY21:
−0.24
FY22:
−142
FY23:
50.7
FY24:
−51.8
FY25:
66.1
Change from FY21 to FY25
millions USD
FY21:
112
FY22:
102
FY23:
−1.55
FY24:
121
FY25:
−0.75
millions USD
FY21:
98.0
FY22:
−70.1
FY23:
6.52
FY24:
3.59
FY25:
1.69
(positive)
Change from FY21 to FY25
millions USD
FY21:
−14.2
FY22:
−32.3
FY23:
−43.9
FY24:
−68.4
FY25:
−65.3
All amounts in millions USD